(S,R,S)-AHPC-PEG1-NH2 hydrochloride is a high-purity E3 Ligase Ligand-Linker Conjugate specifically engineered for use in PROTAC (Proteolysis Targeting Chimera) drug discovery and research. This compound features the VHL (Von Hippel-Lindau) ligand AHPC tethered to a short PEG1 linker, terminating in a reactive amine (NH2) group, and supplied as a hydrochloride salt for enhanced solubility and stability. As a crucial starting point for PROTAC synthesis, (S,R,S)-AHPC-PEG1-NH2 enables the efficient recruitment of the VHL E3 ligase to targeted proteins, facilitating their ubiquitination and subsequent proteasomal degradation. This ligand-linker conjugate is widely used for constructing custom PROTACs aimed at degrading disease-relevant proteins, accelerating research in oncology, neurodegeneration, and other therapeutic areas. Ideal for medicinal chemists and researchers, this product supports the rapid development of novel protein degradation strategies. Category: E3 Ligase Ligand-Linker Conjugate.
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-PEG1-NH2 hydrochloride is a versatile E3 ligase ligand-linker conjugate based on the AHPC (3-amino-2-hydroxy-4-phenylbutanoic acid) scaffold. It is designed to facilitate targeted protein degradation through the proteolysis targeting chimera (PROTAC) approach. The incorporation of a hydrophilic PEG1 linker and terminal amine functionality enables convenient conjugation to various target-binding ligands, making this compound an essential building block for rational PROTAC design.
Mechanism
(S,R,S)-AHPC-PEG1-NH2 hydrochloride operates as a cereblon (CRBN) E3 ligase ligand. When covalently linked via the PEG1 spacer to a ligand that binds a protein of interest, this bifunctional molecule induces the formation of a ternary complex between the target protein, the PROTAC, and the CRBN E3 ubiquitin ligase. Recruitment of CRBN leads to ubiquitination of the target protein, marking it for proteasomal degradation. The PEG1 linker introduces flexibility and hydrophilicity, potentially improving the pharmacokinetic and physicochemical properties of the resulting PROTAC.
Applications
This E3 ligase ligand-linker conjugate is widely used in the discovery and development of PROTAC molecules. (S,R,S)-AHPC-PEG1-NH2 hydrochloride enables researchers to efficiently synthesize novel PROTACs for targeted protein degradation studies, mechanism-of-action investigations, and drug discovery programs across oncology, neurodegenerative diseases, and immunology. Its modular design streamlines structure-activity relationship (SAR) studies and accelerates the optimization of PROTAC efficacy, selectivity, and drug-like properties.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.